Method for enhancing osseointegration of clinical implant

By extracting P148 from the amylogen protein and assembling it with chitosan and hyaluronic acid, LbL technology is used to form a sustainable release coating, which solves the problem of amylogen protein being easily degraded on the titanium surface and significantly enhances osteogenesis of osteocytes Differentiation and osteointegration improve the osteointegration effect of clinical implants.

CN118976145APending Publication Date: 2024-11-19FOURTH MILITARY MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411101470.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

In the environment of disease such as diabetes and osteoporosis, when traditional chitosan coated titanium surface is used to sustainably release miRNA, polypeptide or growth factor, amethogen P148 is easily degraded by bioenzymes, resulting in inflammatory responses and rejection reactions, affecting bones Combined effect.

Method used

By extracting P148 from the enamel matrix protein and combining chitosan and hyaluronic acid for layer-by-layer assembly, chemical coupling is used to form a coating that can sustainably release P148, enhancing the titanium surface Osseobinosis ability.

Benefits of technology

In the rat in vivo model, the P148 functionalized implant significantly enhanced osteogenic differentiation and osteointegration of osteocytes, reduced rejection, and improved the osteobination effect of clinical implants.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976145A_ABST
    Figure CN118976145A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of clinical implant orthopedics, and particularly relates to a method for enhancing synostosis of a clinical implant, which comprises the following steps: S1, extracting a second molar of the lower jaw of a pig, and adding PBS to manufacture a developing enamel white body; s2, the developed enamel white body is placed in a container, guanidine hydrochloride is added, then centrifugal preparation is carried out through centrifugal equipment, and finally glaze original protein powder is obtained through supernatant dialysis separation. According to the present invention, the P148 is subjected to the layer-by-layer assembly to further achieve the long-term protection and slow release of the P148 through the layer-by-layer assembly of the chitosan and the hyaluronic acid, the chemical coupling of the biological layer is promoted by using the LbL technology, the coating can continuously release the P148, the classical pathway ERK1 / 2 signal pathway of the MAPK may be the mechanism for promoting the osteogenic differentiation of the BMSCs, and in the in vivo model of the rat, the P148 can be continuously released; the P148 functionalized Ti implant obviously enhances osteogenic differentiation and osseointegration of the BMSCs, so that the osseointegration of a clinical implant is enhanced, and the rejection is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of clinical implant orthopedics, and in particular relates to a method for enhancing the bone integration of a clinical implant. Background Art

[0002] Titanium has been widely used as an implant material due to its good bone integration ability and excellent biocompatibility, but in disease environments such as diabetes and osteoporosis, the osteogenesis effect around the implant is greatly weakened.

[0003] At present, traditional chitosan-coated titanium surfaces are used to slowly release miRNA, peptides or growth factors. Due to the good biocompatibility and biosafety of chitosan (CS) and hyaluronic acid (HA), their functionalized implant surfaces can well enhance bone integration. Our research group successfully separated a single component of amelogenin P148 from enamel matrix protein (EMD) for the first time. Our previous studies have found that it has strong osteogenic ability. However, when P148 is directly applied as a coating on the implant surface, it will face sudden release, rapid degradation by biological enzymes such as MMP-2 and 9, and possible inflammatory reactions, thereby causing rejection. Summary of the invention

[0004] The purpose of the present invention is to provide a method for enhancing the bone integration of clinical implants, aiming to solve the problem that the traditional chitosan-coated titanium surface is used to slowly release miRNA, peptides or growth factors, etc. Due to the good biocompatibility and biosafety of chitosan (CS) and hyaluronic acid (HA), the functionalized implant surface can well enhance bone integration. Our research group successfully separated the single component amelogenin P148 from the enamel matrix protein (EMD) for the first time. Our previous studies found that it has strong osteogenic ability. However, when P148 is directly applied as a coating on the implant surface, it will face the problem of sudden release, rapid degradation by biological enzymes such as MMP-2 and 9, and possible inflammatory reaction, thereby causing rejection.

[0005] To achieve the above object, the present invention provides the following technical solution: a method for enhancing the bone integration of a clinical implant, comprising the following steps:

[0006] S1. After extracting the second molar of the mandible of the pig, PBS (phosphate buffered saline) was added to make a white blank for developing enamel;

[0007] S2, placing the developed enamel blank into a container and adding guanidine hydrochloride, then centrifuging it using a centrifugal device, and finally dialysis-separating and freeze-drying the supernatant to obtain amelogenin powder;

[0008] S3, mixing the amelogenin powder with guanidine hydrochloride, and performing secondary centrifugation preparation using a centrifugal device, collecting the material attached to the surface as a chromatographic sample and collecting it into a sample bottle;

[0009] S4, testing the crudely extracted amelogenin, the positions of P173, P161, P148 and TRAP can be determined according to the marker, and P148 is extracted;

[0010] S5, placing the titanium disc implant and dopamine into a container, and obtaining a polydopamine-coated implant under the action of self-polymerization;

[0011] S6, overnight treatment of the polydopamine-coated implant, followed by washing and curling after assembling the modified chitosan on the surface of the polydopamine-coated implant;

[0012] S7, completing the above-mentioned step of assembling the modified hyaluronic acid and the extracted P148 on the surface of the polydopamine-coated implant at a pH value of 7.4;

[0013] S8. Repeat the cycle S6 to S7 to perform repeated washing and curling to obtain a polydopamine-coated titanium sheet implant.

[0014] As a preferred method for enhancing bone integration of clinical implants of the present invention, the PBS (phosphate buffered saline) in S1 is 4 degrees Celsius.

[0015] As a preferred method of enhancing bone integration of clinical implants of the present invention, the parameters of the centrifugal devices in S2 and S3 are: a rotation speed of 14000 rcf, a temperature of 4 degrees Celsius, and a running time of 20 minutes.

[0016] As a preferred method for enhancing bone integration of clinical implants of the present invention, SDS-PAGE is used to test the crude extracted amelogenin in S4.

[0017] As a preferred method of enhancing bone integration of clinical implants of the present invention, the polydopamine-coated implants in S5 and S6 need to be operated at a pH value of 8.5.

[0018] As a preferred method for enhancing bone integration of clinical implants of the present invention, the washing and curling times in S6 are 5 minutes respectively.

[0019] As a preferred method of enhancing bone integration of clinical implants of the present invention, the washing and curling in S6 are both performed at a pH value of 7.4.

[0020] As a preferred method for enhancing bone integration of clinical implants of the present invention, the number of cyclic washing and curling in S8 is 10 times.

[0021] As a preferred method of enhancing bone integration of clinical implants of the present invention, the centrifugal device model in S2 and S3 is: TD3WS.

[0022] As a preferred method of enhancing bone integration of clinical implants according to the present invention, the described.

[0023] Compared with the prior art, the present invention has the following beneficial effects:

[0024] By extracting the most abundant P148 component from the mixture of enamel matrix derivatives, and further assembling it layer by layer through chitosan and hyaluronic acid to achieve long-term protection and sustained release of P148, and using LbL technology to promote chemical coupling with the biological layer composed of CS and HA, the coating can sustainably release P148. The classical MAPK pathway ERK1 / 2 signaling pathway may be its mechanism for promoting the osteogenic differentiation of BMSCs. In the in vivo rat model, the P148-functionalized Ti implant significantly enhanced the osteogenic differentiation and bone integration of BMSCs, thereby enhancing the bone integration of clinical implants and reducing rejection. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:

[0026] Figure 1 It is a schematic diagram of the process of the present invention;

[0027] Figure 2 This is a schematic diagram of the separation and purification process of amelogenin of the present invention;

[0028] Figure 3 It is a schematic diagram of the assembly of the titanium surface and implant of the present invention;

[0029] Figure 4 This is a schematic diagram of the titanium surface under an electron microscope of the present invention;

[0030] Figure 5 It is a schematic diagram of the surface roughness of 2D and 3D reconstruction of titanium images under atomic force microscopy of the present invention. DETAILED DESCRIPTION

[0031] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0032] Embodiment 1:

[0033] See also Figure 1-5 The present invention provides the following technical solution: A method for enhancing the bone integration of a clinical implant, comprising the following steps:

[0034] S1. After extracting the second molar of the mandible of the pig, PBS (phosphate buffered saline) was added to make a white blank for developing enamel;

[0035] S2, placing the developed enamel blank into a container and adding guanidine hydrochloride, then centrifuging it using a centrifugal device, and finally dialysis-separating and freeze-drying the supernatant to obtain amelogenin powder;

[0036] S3, mixing the amelogenin powder with guanidine hydrochloride, and performing secondary centrifugation preparation using a centrifugal device, collecting the material attached to the surface as a chromatographic sample and collecting it into a sample bottle;

[0037] S4, testing the crudely extracted amelogenin, the positions of P173, P161, P148 and TRAP can be determined according to the marker, and P148 is extracted;

[0038] Among them, after the mixture of enamel matrix derivatives was tested by SDS-PAGE electrophoresis, more than a dozen protein bands could be seen in the gel strips. Based on the comparison with the protein marker and the sample information of porcine amelogenin, it can be inferred that the marked bands are 23, 20, 17, and 5 KDa protein bands specific to porcine amelogenin. The presence of these four protein bands is a typical characteristic of porcine amelogenin matrix, and the corresponding high-phase liquid chromatography also assisted in the proof. P148 protein, P173, P161, and TRAP were separated and purified by reversed-phase high-phase liquid chromatography. The purified P148 was subjected to electrophoresis, matrix-assisted laser desorption ionization time-of-flight, and mass spectrometry analysis, and it can be seen that there are no other components except protein P148.

[0039] According to previous research reports, the large molecular weight protein in amelogenin is conducive to osteogenic differentiation, and the small molecular component has more angiogenic potential, so we studied the promotion of osteogenic gene expression by P173, P161 and P148. The results of qRT-PCR showed that P148 protein has stronger osteogenic ability. Different concentrations of P148 were added to BMSCs for co-culture, and the absorbance values ​​were measured at 1, 3, 5 and 7 days. The results showed that a concentration of 100ng / ml of P148 could also promote cell proliferation;

[0040] S5, placing the titanium disc implant and dopamine into a container, and obtaining a polydopamine-coated implant under the action of self-polymerization;

[0041] S6, overnight treatment of the polydopamine-coated implant, followed by washing and curling after assembling the modified chitosan on the surface of the polydopamine-coated implant;

[0042] S7, completing the above-mentioned step of assembling the modified hyaluronic acid and the extracted P148 on the surface of the polydopamine-coated implant at a pH value of 7.4;

[0043] S8, repeating the cycle S6 to S7 to perform repeated washing and curling to obtain a polydopamine-coated titanium sheet implant;

[0044] It should be noted that by extracting the most abundant P148 component from the mixture of enamel matrix derivatives, and further assembling chitosan and hyaluronic acid layer by layer to achieve long-term protection and sustained release of P148, and using LbL technology to promote chemical coupling with the biological layer composed of CS and HA, the coating can continuously release P148, and the classical MAPK pathway ERK1 / 2 signaling pathway may be its mechanism for promoting the osteogenic differentiation of BMSCs. In the in vivo rat model, the P148-functionalized Ti implant significantly enhanced the osteogenic differentiation and bone integration of BMSCs, thereby enhancing the bone integration of clinical implants and reducing rejection.

[0045] It is more important to note that natural porcine amelogenin P148 was extracted and purified according to the above method. Briefly, we dissected fresh tooth germs from the mandibles of 6-month-old pigs. The amelogenin mixture was extracted from the tooth germ enamel matrix with acetic acid and then highly purified after freeze-drying using RP-HPLC under predetermined chromatographic conditions. The eluate containing natural amelogenin P148 was collected using a fraction collector and then freeze-dried. The high purity and composition of the freeze-dried powder were confirmed by matrix-assisted laser desorption / ionization time-of-flight mass spectrometry (Bruker Daltonics, Bremen, Germany) and high-resolution mass spectrometry trari-TOF5600+ (ABSCIEX, Concord, Canada).

[0046] Preferably, the PBS (phosphate buffered saline) in S1 is at 4 degrees Celsius.

[0047] Preferably, the parameters of the centrifugal devices in S2 and S3 are: a rotation speed of 14000 rcf, a temperature of 4 degrees Celsius, and a running time of 20 minutes.

[0048] Preferably, the crude extracted amelogenin is tested by SDS-PAGE in S4.

[0049] Preferably: the polydopamine coated implants in S5 and S6 need to be operated at a pH value of 8.5, the washing and curling time are 5 minutes respectively, and the washing and curling are both performed at a pH value of 7.4.

[0050] Preferably: the number of cycles of washing and curling in S8 is 10 times;

[0051] Preferably, the centrifugal equipment model in S2 and S3 is: TD3WS.

[0052] It should be noted that primary BMSCs were isolated and cultured as previously described. Briefly, 2-week-old SD rats were killed and disinfected with 75% alcohol for 15 min, and the stripped tibiae and femurs were immersed in PBS containing double-antibody. In a sterile environment, the bone marrow cavity was flushed several times with α-MEM (α-MEM, Gibco). The cell suspension was centrifuged at 800 rpm for 5 min and resuspended in α-MEM supplemented with 10% fetal bovine serum (FBS; HyClone) and 1% (v / v) penicillin / streptomycin (P / S; HyClone). The culture medium was replaced every 3 days, and 2-3 passages of mesenchymal stem cells were used for subsequent experiments.

[0053] To determine the effect of different concentrations of P148 on the proliferation of BMSCs, we seeded 96-well plates and counted them using a cell counting plate, seeding 1000 BMSCs per well. The plates were then placed in an incubator at 37°C and 5% carbon dioxide, and the cell counting kit 8 from Gipbio, Montclair, USA, was used after 1, 3, 5, and 7 days, and incubated in a 37°C incubator for 2 hours. The optical density at 450 nm was measured using a microplate reader (Spectramax, US) to calculate the percentage of cell viability.

[0054] The cytotoxicity of different samples was detected using the LIVE / DEAD viability / cytotoxicity kit (Thermo, USA). BMSCs (5×104 cells / well) were seeded on different samples and cultured for 24 h, then the cells were digested with trypsin, stained with a working solution containing 2 μM calcein-AM and 8 μM propidium iodide (PI), and observed under a fluorescence microscope.

[0055] We used confocal microscopy to observe the initial adhesion of BMSCs on each sample. First, BMSCs (5 × 104 cells / well) were placed on different Ti samples (10 mm × 10 mm × 1 mm) and incubated for 1, 4, and 24 h, respectively. After incubation, non-adherent cells and impurities were carefully rinsed with PBS. Then, the attached BMSCs on the titanium sheet were fixed in 4% PFA (Solarbio, China) for 30 min, permeabilized with 0.2% TritonX-100 at 25 °C for 20 min, and blocked with 1% bovine serum albumin at 37 °C for 1 h. Finally, BMSCs were stained with phalloidin and DAPI (Beyotime) in the dark. The stained BMSCs were observed using a confocal microscope (Nikon A1+ / A1R+, Tokyo, Japan).

[0056] EDU detection was performed according to the reagent manufacturer's instructions (Beyotime, China). Cells were exposed to 1× EDU working solution for 48 hours and fixed with 4% paraformaldehyde (Solarbio, China). Azide488 reagent was then added to bind to the EDU taken up in the cells to display red light, and the cell nuclei were stained with Hoechst. Finally, the samples were visualized using a Nikon microscope;

[0057] 5×104 cells were inoculated in each well, and each group was treated differently. After 7 days of culture, the cells on the Ti sample were washed with PBS, fixed with 4% paraformaldehyde (Solarbio, China), and ALP was stained with Beyotime's BCIP / NBTALP colorimetric kit for 30 minutes. The samples were thoroughly washed with PBS, observed and photographed under a microscope, and the staining results were quantified using the ALP detection kit. After 21 days of culture, the cells were washed twice with PBS, fixed with 4% paraformaldehyde, and the ECM mineralized nodules formed by BMSCs culture were stained with ARS (Beyotime, China) for about 30 minutes. The images were taken after thorough washing with distilled water. The mineralized calcium nodules were dissolved using 10% hexadecylpyridinium chloride for semi-quantitative analysis;

[0058] It is worth noting that LBL is an effective method for preparing new materials by sequential deposition, and its best feature is its excellent sustained release effect. CS is a biodegradable natural polymer, which is the product of the removal of some acetyl groups from the natural polysaccharide chitin. It has physiological functions such as biodegradability, biocompatibility, and non-toxicity. CS can react with other materials through interactions such as electrostatic forces, hydrogen bonds, and Schiff base bonds, which theoretically supports the preparation of chitosan-based functionalized materials by LBL operation. Since CS and HA exhibit opposite charge groups (CS is positively charged and HA is negatively charged), functionalized titanium surfaces are obtained by superimposing alternating coatings of polyanionic and polycationic coatings on implants. LBL technology has the advantages of easy operation and low cost, and the thickness of the coating bilayer is controllable. Polydopamine (PDA)-assisted surface modification has received considerable attention in the past few years. In addition to its strong bioadhesive properties, it is also used as a surface modifier to enhance the interfacial properties of implants, so dopamine is another favorable choice for LBL modification. Our research group has previously successfully constructed a nano / gel sustained-release system carrying miRNA138, which significantly promoted skull regeneration in rats, and successfully constructed CS / HA nanoparticles of miRNA21 to promote bone integration on implant surfaces.

[0059] Embodiment 2:

[0060] See also Figure 1-5 , 3-month-old female SD rats were selected for the experiment;

[0061] The experiment was divided into four groups (4 rats in each group): 1) Blank group: untreated implants were implanted in SD rats, 2) PDA group: PDA implants were implanted in SD rats, 3) PDA+LBL group: PDA+LBL coated implants were implanted in SD rats, 4) PDA+LBL+P148 group: CS / P148 functionalized implants were implanted in SD rats. The implants used in this study were from Kang Medical (Xi'an, China), with an implant length of 5 mm and a diameter of 2 mm. Rats were anesthetized with 1% sodium pentobarbital solution (45 mg / kg), and the hind limbs were cleaned with ethanol and iodine. An incision was made at the distal end of the knee joint, the muscles and ligaments were moved to both sides, a triangular pyramid was used to drill a hole, and the treated implant was screwed vertically into the femur. The animals were killed 8 weeks after implantation, and the femurs were removed for imaging and histological analysis;

[0062] It should be noted that animal experiments need to be reported and various procedures must be obtained from relevant departments.

[0063] Specimens (femurs with implants) (n = 3 per group) were fixed in 4% paraformaldehyde for 24 h. Subsequently, peri-implant bone fusion was analyzed using micro-computed tomography (Siemens, Erlangen, Germany). The region of interest (ROI) was reconstructed into a three-dimensional structure at a distance of approximately 50 μm from the implant surface, and various morphometric parameters related to peri-implant bone were analyzed, including bone volume percentage (BV / TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp).

[0064] After micro-CT scanning, the specimens were dehydrated with graded alcohol gradients and embedded in methyl methacrylate. Then, sections were cut parallel to the long axis of the implant, and the sections were further polished and stained with 1.2% trinitrophenol and 1% acid purple red (Van Gieson staining). Finally, bone formation was qualitatively analyzed using a standard light microscope (M80, Leica, Germany) equipped with a digital image analysis system (Image-ProPlus software, USA). At the same time, bone-implant contact (BIC) was also determined.

[0065] Embodiment three:

[0066] See also Figure 1-5For immunofluorescence analysis, BMSCs (5×104 cells) were seeded in 35 mm laser confocal culture dishes for 24 h and starved in serum-free medium for 24 h. Then they were randomly divided into four groups: CON, U0126, U0126+P148, and P148. The cells in the U0126 and U0126+P148 groups were first treated with 10 mM p-ERK1 / 2 inhibitor U0126 for 1 h. Then, 1 mM P148 diluted in serum-free medium was added to stimulate the cells in the P148 and U0126+P148 groups for 1 h. The cells were fixed in 4% paraformaldehyde for 15 min. The cells were incubated with anti-ERK1 / 2 (AF1051, Beyotime) and P-ERK1 / 2 (AG2954, Beyotime) at 4°C overnight. Afterwards, cells were incubated with goat anti-rabbit IgG (H+L) CoraLite594-coupled (SA00013-2, Proteintech) or CoraLite594-coupled goat anti-rabbit IgG (H+L) (SA00013-4, Proteintech) at room temperature for 2 hours. Cell nuclei were stained with DAPI. Immunofluorescence sections and cells were examined and imaged using a laser scanning confocal microscope (NikonA1+ / A1R+, Tokyo, Japan);

[0067] P148 coating loading and release rates;

[0068] The P148 protein was loaded and released at the titanium surface coating time points, and the layer-by-layer loaded P148 was subsequently calculated. The accumulated P148 loading amount on the titanium surface gradually increased with the increase in the number of layers, indicating that the LbL method can be used to control the loading amount of P148. The results of FITC fluorescently labeled P148 under confocal microscopy were consistent with the loading rate trend. From the fluorescence image, P148 can be well loaded onto the titanium surface through layer-by-layer assembly, and the protein distribution is relatively uniform. In order to show the release of P148, after layer-by-layer scanning, the three-dimensional image was reconstructed by software, and the number of P148 after immersion in the culture medium for 1, 3, and 7 days was displayed. After 7 days, a certain amount of P148 was still retained on the titanium sheet, indicating that the titanium surface treated with LBL can continuously release P148 protein, and achieve stable release of P148 from the functionalized Ti surface, so that there is no obvious initial burst release. In the first 4 days, nearly 50% of the loaded protein was released from the functionalized surface, and it was basically completely released after 20 days. The results show that the loading method of P148 on the titanium surface through LBL can achieve a relatively excellent drug delivery method, which solves the shortcomings of P148 such as easy hydrolysis and short action time.

[0069] Embodiment 4:

[0070] See also Figure 1-5 , surface topography and characterization;

[0071] In order to stably and effectively fix the coating on the titanium surface, we used the PDA coating chemical method. The PDA layer was first coated on the titanium sheet or implant surface; this was done by depositing it in a dopamine chloride solution (2mgmL-1 in 10mMTris-HCl, pH8.5), incubating it at room temperature in the dark for 24 hours, and then loading the chitosan and hyaluronic acid coatings on the adhesive PDA coating film.

[0072] The modified titanium surface was observed by scanning electron microscopy (SEM). The acid-etched titanium surface of the control group showed a typical acid-etched rod-like structure. After dopamine treatment, the surface roughness was reduced, and a small amount of granular dopamine was formed and evenly distributed on the titanium surface. The acid-etched raised rods became relatively smooth on the LBL-functionalized and CS / P148-functionalized surfaces. The two-dimensional and three-dimensional results of AFM were consistent with the results of SEM observation. The root mean square roughness, peak-to-valley roughness, irregular space and surface area after self-assembly coating were significantly reduced. Due to the presence of the adhesive PDA, the acid-etched surface roughness after PDA coating was reduced, and the roughness of the LBL and P148-loaded functionalized surfaces was further reduced, indicating that the coating can change the surface roughness of the material. The micro / nanomorphology may promote the activity of osteoblast lineage cells and provide a more favorable osteogenic microenvironment.

[0073] During the growth process of P148 functionalized titanium surface, we monitored the wettability of titanium surfaces with different treatments. The hydrophilicity of the implant surface plays a crucial role in liquid penetration and cell adhesion. A significant decrease in static water contact angle was observed on the surfaces of PDA, PDA+LBL, and PDA+LBL+P148. The water contact angle on the CON surface was (57±2.7)°, while after PDA coating, the water contact angle decreased to (34.07±4.1)°. However, with the layer-by-layer assembly of positively and negatively charged polyelectrolytes, the hydrophilicity of PDA+LBL and PDA+LBL+P148 functionalized titanium surfaces did not significantly improve. This result indicates that PDA coating can significantly change the hydrophilicity of titanium surface, and the immobilization of LBL and P148 has little effect on the physical properties of Ti substrate, which is consistent with the experimental results of Wu et al. Previous studies have also shown that the deposition of PDA on the Ti surface can significantly improve the surface wettability. The hydrophilicity of the material surface affects the cell behavior at the interface between the implant surface and the host surrounding tissue.

[0074] Embodiment five:

[0075] See also Figure 1-5 , Cytotoxicity, adhesion, and proliferation of BMSCs on 4CS / P148 functionalized titanium surfaces;

[0076] The cell compatibility of modified titanium surfaces in in vitro experiments, the primary criteria for the use of bone implants in clinical practice are biosafety and biocompatibility. In order to better understand the cytotoxicity of different Ti substrates, we performed LIVE / DEAD cell staining. There was no significant difference in live cell staining among the four groups, and the number of red dead cells was small. The results showed that the CS functionalized surface has good biocompatibility.

[0077] Cell adhesion and extension are the first steps of proliferation and differentiation, and play a vital role in the initial stage of bone regeneration. In this study, rat BMSCs were inoculated onto different substrate surfaces for culture and stained after 1, 4, and 24 hours. The cell adhesion fluorescence images of different samples at 1 hour showed that BMSCs on CON, PDA, and PDA+LBL were mostly round or elliptical. In contrast, cells on the P148 functionalized surface began to show a polygonal shape. When the time was extended to 4 and 24 hours, more plate-like or filamentous pseudopodia could be observed on the P148 titanium surface, connecting the surrounding cells through a reticular pattern, showing its good cytoskeleton extension and excellent cell-to-cell interaction. At 48 hours, the incorporation of red fluorescent EDU was found in the proliferating BMSCs in each group, and the proliferation of cells on the P148 functionalized titanium surface was significant.

[0078] Embodiment six:

[0079] See also Figure 1-5 , Effect of 5CS / P148 functionalized titanium surface on in vitro osteogenesis;

[0080] The production of ALP after 7 days of culture and the mineralization of EMC after 21 days were evaluated. The ALP activity assay showed that BMSCs attached to the P148 surface showed the highest ALP activity, and there was no significant difference in the level of ALP production induced in the CON, PDA, and PAD+LBL functionalized surfaces. Semi-quantitative results showed that there was a significant difference in the P148 group. After culturing cells on the four different surfaces for 21 days, the ECM mineralized nodules were stained with Alizarin Red. The P148 group produced the most mineralized nodules. The semi-quantitative results showed that the number of mineralized nodules induced by the P148 functionalized surface was significantly higher than that of the other groups, which was consistent with the ALP results.

[0081] Real-time fluorescence quantitative PCR was used to detect the expression levels of osteogenic-related genes on different samples. The expression levels of OPN, OSX, RUNX2 and COL1 induced by BMSCs on P148-functionalized titanium surfaces were significantly higher than those on CON, PDA and PDA+LBL functionalized surfaces, and because dopamine has a weak effect on promoting osteogenics, the gene expression was higher than that in the control group. However, simply promoting gene transcription does not guarantee good osteogenic activity. Only when it directly participates in the osteogenic process and exerts biological functions can downstream translated proteins produce osteogenic effects. The WB experimental results are consistent with the trend of osteogenic gene expression, showing that the expression of osteogenic gene proteins in the P148-functionalized group is significantly higher than that in other groups. PCR and WB evaluated the osteogenic ability of different titanium surfaces in terms of gene and protein expression, respectively. Wang et al. also used this research method to observe the osteogenic status of titanium surfaces after different treatments.

[0082] Working principle: After extracting the second molar of the mandibular pig, add PBS (phosphate buffered saline) to make a white enamel blank. Place the white enamel blank in a container and add guanidine hydrochloride. Then use a centrifugal device to centrifuge and prepare it. Finally, use the supernatant to dialyze and separate it for freeze-drying to obtain amelogenin powder. Mix the amelogenin powder with guanidine hydrochloride and use a centrifugal device to prepare it for secondary centrifugation. Collect the material attached to the surface as a chromatographic sample and collect it in a sample bottle. Test the crude extracted amelogenin. According to the marker, the positions of P173, P161, P148 and TRAP can be determined, and P148 can be extracted. The P148 component with the highest content was extracted from amelogenin, and further long-term protection and sustained release of P148 were achieved through layer-by-layer assembly of chitosan and hyaluronic acid. The LbL technology was used to promote the chemical coupling with the biological layer composed of CS and HA. The coating can continuously release P148. The classic MAPK pathway ERK1 / 2 signaling pathway may be its mechanism for promoting the osteogenic differentiation of BMSCs. In the in vivo rat model, the P148-functionalized Ti implant significantly enhanced the osteogenic differentiation and bone integration of BMSCs, thereby enhancing the bone integration of clinical implants and reducing rejection.

[0083] Finally, it should be noted that the above are only preferred embodiments of the present invention and are not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for enhancing bone integration of clinical implants, characterized in that: The following steps are involved: S1. After extracting the second molar of the mandible of the pig, PBS (phosphate buffered saline) was added to make a white blank for developing enamel; S2, placing the developed enamel blank into a container and adding guanidine hydrochloride, then centrifuging it using a centrifugal device, and finally dialysis-separating and freeze-drying the supernatant to obtain amelogenin powder; S3, mixing the amelogenin powder with guanidine hydrochloride, and performing secondary centrifugation preparation using a centrifugal device, collecting the material attached to the surface as a chromatographic sample and collecting it into a sample bottle; S4, testing the crudely extracted amelogenin, the positions of P173, P161, P148 and TRAP can be determined according to the markers, and P148 is extracted; S5, placing the titanium disc implant and dopamine into a container, and obtaining a polydopamine-coated implant under the action of self-polymerization; S6, overnight treatment of the polydopamine-coated implant, followed by washing and curling after assembling the modified chitosan on the surface of the polydopamine-coated implant; S7, completing the above-mentioned step of assembling the modified hyaluronic acid and the extracted P148 on the surface of the polydopamine-coated implant at a pH value of 7.4; S8. Repeat the cycle S6 to S7 to perform repeated washing and curling to obtain a polydopamine-coated titanium sheet implant.

2. A method for enhancing bone integration of clinical implants according to claim 1, characterized in that: The PBS (phosphate buffered saline) in the S1 is at 4 degrees Celsius.

3. A method for enhancing bone integration of clinical implants according to claim 1, characterized in that: The parameters of the centrifugal devices in S2 and S3 are: rotation speed of 14000 rcf, temperature of 4 degrees Celsius, and running time of 20 minutes.

4. A method for enhancing bone integration of clinical implants according to claim 1, characterized in that: In S4, the crude extracted amelogenin was tested by SDS-PAGE.

5. The method for enhancing bone integration of clinical implants according to claim 1, characterized in that: The polydopamine-coated implants in S5 and S6 need to be operated at a pH value of 8.

5.

6. A method for enhancing bone integration of clinical implants according to claim 1, characterized in that: The washing and curling times in S6 are 5 minutes respectively.

7. A method for enhancing bone integration of clinical implants according to claim 1, characterized in that: In S6, washing and curling are both performed at a pH value of 7.

4.

8. The method for enhancing bone integration of clinical implants according to claim 1, characterized in that: The number of cycles of washing and curling in S8 is 10 times.

9. The method for enhancing bone integration of clinical implants according to claim 1, characterized in that: The centrifugal equipment model in S2 and S3 is: TD3WS.